Evaluating the Safety and Immunogenicity of MTBVAC

Abroad (travel likely)RecruitingPHASE2

Conditions

HIV I Infection · Tuberculosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Soweto - Gauteng, Johannesburg, Gauteng, South Africa
Johannesburg - CHRU, Westdene, Gauteng, South Africa
Contact: Study coordinator (Anne Reyneke) · areyneke@witshealth.co.za · 27-11-2768800
Durban - Botha's Hill CRS, Durban, KwaZulu-Natal, South Africa
Contact: Study coordinator (Ncamsile Sibisi) · Ncamsile.Sibisi@mrc.ac.za · 27-31-2423600
Durban - Wentworth, Durban, KwaZulu-Natal, South Africa
Cape Town - UCTLI, Cape Town, Western Cape, South Africa
Contact: Study coordinator (Catrien Drinkwater) · catrien.drinkwater@uct.ac.za · 27-21-4066850
Cape Town - Emavundleni, Cape Town, Western Cape, South Africa
Cape Town - Groote Schuur, Cape Town, Western Cape, South Africa
Contact: Study coordinator (Doerieyah Reynolds) · Doerieyah.Reynolds@hiv-research.org.za · 27-21-6501891
Worcester - SATVI, Worcester, Western Cape, South Africa
Contact: Study coordinator (Lynnett Stone) · Lynnett.Stone@uct.ac.za · 27-23-3465400
Cape Town - Khayelitsha, Cape Town, South Africa
Contact: Study coordinator (Rene Goliath) · Rt.goliath@uct.ac.za · 27-21-6501938
Durban - Chatsworth, Chatsworth, South Africa
Contact: Study coordinator (Lakshmi Baboolall) · Lakshmi.Baboolall@mrc.ac.za · 27-031-4014150
Durban eThekwini, Durban, South Africa
Durban - Isipingo, Isipingo, South Africa
Contact: Study coordinator (Girisha Kistnasami) · girisha.kistnasami@mrc.ac.za · 27-31-9027494
Klerksdorp, Klerksdorp, South Africa
Contact: Study coordinator (Olebogeng Jonkane) · ojonkane@auruminstitute.org · 27(0)87 135 1602
Ladysmith, Ladysmith, South Africa
Contact: Study coordinator (Michelle Nelson) · michelle01qm@gmail.com · 27-36-6312372
Study coordinator · 27-36-6312372
Rustenburg CRS, Rustenburg, South Africa
Soshanguve, Soshanguve, South Africa

Study leads

Mark Hatherill
Study Chair
South African Tuberculosis Vaccine Initiative
Limakatso Lebina
Study Chair
Africa Health Research Institute (AHRI)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Tatelo Plus Study

HIV · HIV Infections

Abroad (travel likely)RecruitingPHASE1, PHASE2

Francistown, Botswana · Gaborone, Botswana

Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy

HIV I Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Melbourne, Australia · Singapore, Singapore

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

Tuberculous Meningitis · HIV I Infection

Abroad (travel likely)RecruitingPHASE2

Rio de Janeiro, Brazil · Maputo, Mozambique

#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.

HIV Infection · HIV · Stigma

Abroad (travel likely)Recruiting

Ghent, Belgium · Marseille, France